A citation-based method for searching scientific literature

Marc D Schwartz, Beth N Peshkin, Claudine Isaacs, Shawna Willey, Heiddis B Valdimarsdottir, Rachel Nusbaum, Gillian Hooker, Suzanne O'Neill, Lina Jandorf, Scott P Kelly, Jessica Heinzmann, Aliza Zidell, Katia Khoury. Breast Cancer Res Treat 2018
Times Cited: 9







List of co-cited articles
37 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
151
44

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
44

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
33

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
148
33

Preoperative genetic testing affects surgical decision making in breast cancer patients.
Elizabeth Lokich, Ashley Stuckey, Christina Raker, Jennifer Scalia Wilbur, Jessica Laprise, Jennifer Gass. Gynecol Oncol 2014
28
33

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Eric R Manahan, Henry M Kuerer, Molly Sebastian, Kevin S Hughes, Judy C Boughey, David M Euhus, Susan K Boolbol, Walton A Taylor. Ann Surg Oncol 2019
52
33

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
110
33

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
46
33

Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial.
M R Wevers, N K Aaronson, S Verhoef, E M A Bleiker, D E E Hahn, M A Kuenen, J van der Sanden-Melis, T Brouwer, F B L Hogervorst, R B van der Luijt,[...]. Br J Cancer 2014
19
33

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
22

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.
Mary K Interrante, Hannah Segal, Beth N Peshkin, Heiddis B Valdimarsdottir, Rachel Nusbaum, Morgan Similuk, Tiffani DeMarco, Gillian Hooker, Kristi Graves, Claudine Isaacs,[...]. JNCI Cancer Spectr 2017
7
28

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
58
22

Validation of a decisional conflict scale.
A M O'Connor. Med Decis Making 1995
22

Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.
Mary Kathleen Ladd, Beth N Peshkin, Leigha Senter, Shari Baldinger, Claudine Isaacs, Hannah Segal, Samantha Philip, Chloe Phillips, Kate Shane, Aimee Martin,[...]. Transl Behav Med 2020
2
100

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby,[...]. Health Psychol 2009
72
22

BRCA1/2 genetic testing uptake and psychosocial outcomes in men.
Kristi D Graves, Rhoda Gatammah, Beth N Peshkin, Ayelet Krieger, Christy Gell, Heiddis B Valdimarsdottir, Marc D Schwartz. Fam Cancer 2011
17
22

Web Platform vs In-Person Genetic Counselor for Return of Carrier Results From Exome Sequencing: A Randomized Clinical Trial.
Barbara B Biesecker, Katie L Lewis, Kendall L Umstead, Jennifer J Johnston, Erin Turbitt, Kristen P Fishler, John H Patton, Ilana M Miller, Alexis R Heidlebaugh, Leslie G Biesecker. JAMA Intern Med 2018
42
22

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
D F Cella, D S Tulsky, G Gray, B Sarafian, E Linn, A Bonomi, M Silberman, S B Yellen, P Winicour, J Brannon. J Clin Oncol 1993
22

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
189
22

Intentions for bilateral mastectomy among newly diagnosed breast cancer patients.
Lesley King, Suzanne C O'Neill, Elizabeth Spellman, Beth N Peshkin, Heiddis Valdimarsdottir, Shawna Willey, Kara Grace Leventhal, Tiffani DeMarco, Rachel Nusbaum, Elizabeth Feldman,[...]. J Surg Oncol 2013
20
22

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
22

Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Reshma Jagsi, Sarah T Hawley, Kent A Griffith, Nancy K Janz, Allison W Kurian, Kevin C Ward, Ann S Hamilton, Monica Morrow, Steven J Katz. JAMA Surg 2017
72
22

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
325
22

The Brief Symptom Inventory: an introductory report.
L R Derogatis, N Melisaratos. Psychol Med 1983
22


Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Bernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, Margreet G E M Ausems, Johanna M Collée, Liesbeth Jansen, C Marleen Kets, Kristien B M I Keymeulen, Linetta B Koppert, Hanne E J Meijers-Heijboer,[...]. Int J Cancer 2015
82
22

Nationwide trends in mastectomy for early-stage breast cancer.
Kristy L Kummerow, Liping Du, David F Penson, Yu Shyr, Mary A Hooks. JAMA Surg 2015
323
22

Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
116
22

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017
159
22

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Shari Gelber, Lidia Schapira, Steven Come, Virginia F Borges, Bryce Larsen, Judy E Garber, Ann H Partridge. JAMA Oncol 2016
68
22

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
78
22

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Allison W Kurian, Kent A Griffith, Ann S Hamilton, Kevin C Ward, Monica Morrow, Steven J Katz, Reshma Jagsi. JAMA 2017
68
22

Barriers to genetic testing in newly diagnosed breast cancer patients: Do surgeons limit testing?
Laura Hafertepen, Alyssa Pastorino, Nichole Morman, Jennifer Snow, Deepa Halaharvi, Lindsey Byrne, Mark Cripe. Am J Surg 2017
13
22

Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.
Anne Brecht Francken, Philip C Schouten, Eveline M A Bleiker, Sabine C Linn, Emiel J Th Rutgers. Breast 2013
16
22

Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Akiko Chiba, Tanya L Hoskin, Emily J Hallberg, Jodie A Cogswell, Courtney N Heins, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2016
25
22

Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis.
Siddhartha Yadav, Ashley Reeves, Sarah Campian, Amy Sufka, Dana Zakalik. Hered Cancer Clin Pract 2017
15
22

Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
Chris Jacobs, Christine Patch, Susan Michie. Eur J Hum Genet 2019
18
22

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
Anne S Juan, Claire E Wakefield, Nadine A Kasparian, Judy Kirk, Janet Tyler, Kathy Tucker. Genet Test 2008
11
11

Early Outcome Data Assessing Utility of a Post-Test Genomic Counseling Framework for the Scalable Delivery of Precision Health.
Amy C Sturm, Tara Schmidlen, Laura Scheinfeldt, Shelly Hovick, Joseph P McElroy, Amanda E Toland, J Scott Roberts, Kevin Sweet. J Pers Med 2018
3
33

National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko, Christopher P Childers. JAMA Oncol 2018
21
11

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio,[...]. J Clin Oncol 2017
70
11

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
366
11

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
37
11

Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.
Joel Erblich, Karen Brown, Youngmee Kim, Heiddis B Valdimarsdottir, Barbara E Livingston, Dana H Bovbjerg. Patient Educ Couns 2005
47
11

Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.
Beth N Peshkin, Tiffani A Demarco, Kristi D Graves, Karen Brown, Rachel H Nusbaum, Diana Moglia, Andrea Forman, Heiddis Valdimarsdottir, Marc D Schwartz. Genet Test 2008
42
11

The multi-dimensional measure of informed choice: a validation study.
Susan Michie, Elizabeth Dormandy, Theresa M Marteau. Patient Educ Couns 2002
163
11

Immunotherapy for Prostate Cancer: Where We Are Headed.
Giuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, Filippo Martignano, Delia De Lisi, Giorgia Ravaglia, Lorena Rossi, Cecilia Menna, Salvatore Roberto Bellia, Domenico Barone,[...]. Int J Mol Sci 2017
32
11


Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.
Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
55
11

Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.
A Liede, K Metcalfe, D Hanna, E Hoodfar, C Snyder, C Durham, H T Lynch, S A Narod. Am J Hum Genet 2000
67
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.